
Dr. Areej Al-Wabil
Project lead, WarfaRisk
Dr. Areej Al-Wabil is one of the three project leads of WarfaRisk, an open research project on warfarin dose prediction.
Also written: Areej Alwabil.
About WarfaRisk
WarfaRisk is an open research project that predicts a weekly warfarin dose with a 90% range around it, then checks how well that range held up for each ancestry group. It is a research prototype, not tested in patients and not for clinical use.
The project is described in two peer-reviewed papers from 2026. The code and trained models are open.
Links
- Dr. Areej Al-Wabil on LinkedIn
- Email: awabil@alfaisal.edu
- WarfaRisk project page
- WarfaRisk code on GitHub
The rest of the team
- Dr. Mariam AlEissa
- Dr. Abdullah N. Alkattan
- Siraj Aldeen Marghalani
- Omar Bawazir
- Hassan Barmandah
- Muath Shaat
Research prototype. Not tested in patients and not for clinical use. The dose and range shown by WarfaRisk must not be used to make dosing decisions.